Literature DB >> 15749928

Rac2-deficient hematopoietic stem cells show defective interaction with the hematopoietic microenvironment and long-term engraftment failure.

Michael Jansen1, Feng-Chun Yang, José A Cancelas, Jeff R Bailey, David A Williams.   

Abstract

The hematopoietic-specific Rho GTPase, Rac2, regulates a variety of cellular functions including cell shape changes, motility, integrin-dependent adhesion, and apoptosis. In the study reported here, we demonstrate that wild-type (WT) hematopoietic stem cells/progenitors (HSC/P) preferentially engraft in nonablated Rac2(-/-) bone marrow. In addition, primitive Rac2(-/-) HSC/P transplanted into lethally irradiated WT recipients showed a significant competitive defect compared with WT cells. These defects appeared to be related to HSC/P-intrinsic defective microenvironment interactions, since Rac2(-/-) cells showed less adhesion to the femur bone marrow density 1 (FBMD-1) stromal cell line, a lower frequency of cobblestone area-forming cells, and lower performance in long-term marrow cultures in vitro when compared with WT cells. In contrast, primitive Rac2(-/-) hematopoietic cells exhibited normal progenitor colony formation in semisolid medium in vitro and normal proliferation in the steady state in vivo when compared with WT cells. Taken together, these data suggest that Rac2(-/-) stem/progenitor cells exhibit abnormal interaction with the hematopoietic microenvironment, which leads to defective long-term engraftment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749928     DOI: 10.1634/stemcells.2004-0216

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  23 in total

1.  On how Rac controls hematopoietic stem cell activity.

Authors:  J A Cancelas
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton.

Authors:  Theodosia A Kalfa; Suvarnamala Pushkaran; Narla Mohandas; John H Hartwig; Velia M Fowler; James F Johnson; Clinton H Joiner; David A Williams; Yi Zheng
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

Review 3.  Regulation of hematopoiesis and its interaction with stem cell niches.

Authors:  Fumio Arai; Atsushi Hirao; Toshio Suda
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

4.  Rac GTPases play multiple roles in erythropoiesis.

Authors:  Peng Ji; Harvey F Lodish
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

5.  The role of Rac2 in regulating neutrophil production in the bone marrow and circulating neutrophil counts.

Authors:  John C Gomez; Jindrich Soltys; Keiichi Okano; Mary C Dinauer; Claire M Doerschuk
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

Review 6.  Rho GTPases control specific cytoskeleton-dependent functions of hematopoietic stem cells.

Authors:  Ramesh C Nayak; Kyung-Hee Chang; Nataraja-Sarma Vaitinadin; Jose A Cancelas
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

7.  Adhesion, migration, and homing of murine hematopoietic stem cells and progenitors.

Authors:  Jose A Cancelas
Journal:  Methods Mol Biol       Date:  2011

Review 8.  Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders.

Authors:  Anja Troeger; David A Williams
Journal:  Exp Cell Res       Date:  2013-07-11       Impact factor: 3.905

Review 9.  Rho GTPases in hematopoiesis and hemopathies.

Authors:  James C Mulloy; Jose A Cancelas; Marie-Dominique Filippi; Theodosia A Kalfa; Fukun Guo; Yi Zheng
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

10.  Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR.

Authors:  Rong Liang; Gao-Sheng Huang; Zhe Wang; Xie-Qun Chen; Qin-Xian Bai; Yong-Qing Zhang; Bao-Xia Dong; Wen-Qing Wang
Journal:  Int J Hematol       Date:  2008-02-21       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.